- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02579330
Trial on Use of Coloshield in Transanal and Anal Surgery
October 15, 2015 updated by: Daniel Steinemann, MD
Randomized Controlled Trial on Practicability of Coloshield in Transanal and Anal Surgery
In various transanal and anal procedures it is desirable to clean the operating field from stool contamination.
Thus mechanical bowel preparation is not well tolerated by patients.
Enema does not provide sufficient effect.
By the use of Coloshield a rectal washout might be performed and enable a clean operating field.
In this randomized controlled trial the macroscopic contamination of the rectum with and without Coloshield is compared using the Boston Bowel Preparation Score (0-3).
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Daniel C Steinemann, MD
- Phone Number: 0041 61 436 27 04
- Email: daniel.steinemann@ksbl.ch
Study Locations
-
-
-
Bruderholz, Switzerland, 4101
- Kantonsspital Baselland, Department of Surgery, Bruderholz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing surgery for Fistula-in-ano, transanal resection of rectal Polyp or Adenoma, haemorrhoids or anal fissure.
Exclusion Criteria:
- Age <18 years
- inability to give informed consent
- pregnancy
- missing informed consent
- emergency Operation (<24hours of diagnosis and admission at emergency room)
- rectal strictures or Stenosis
- status post rectal resection or pelvic Radiation therapy
- inflammatory bowel disease with inclusion of the rectum
- need for mechanical bowel preparation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Coloshield Group
In the Intervention group the Coloshield Device (double balloon system) will be introduced at the beginning of surgery followed by a washout of the rectum with 500ml of saline solution.
The grade of macroscopic contamination will be assessed.
|
Coloshield is designed to occlude the rectum during surgery thus enabling the possibility for rectal washout and maintaining a clear operating field.
The rod-shaped Instrument contains two silicon balloons which are inflated by means of a catheter.
Several holes at the section in between the two balloons are connected to another catheter, which enable negative pressure to be established.
By insufflation of the two balloons and establishment of a negative pressure between the balloons by means of connection to a closed drainage bottle the colon is occluded for the duration of surgery.
In the control group no device is introduced but a rectal washout with 500ml of Saline solution in performed.
|
SHAM_COMPARATOR: Control Group
In the control Group the grade of macroscopic contamination will be assessed after rectal washout with 500ml of saline solution.
|
In the control group no device is introduced but a rectal washout with 500ml of Saline solution in performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Grade of macroscopic contamination according to adjusted Boston Bowel Preparation Score (0-3).
Time Frame: during initial surgery
|
during initial surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stable position of Coloshield
Time Frame: during initial surgery
|
The position of the deployed Coloshield at beginning of surgery and after 30 minutes is measured by rigid rectoscopy in cm from anal verge.
Any slippage of the device during surgery is documented.
|
during initial surgery
|
Injuries of the rectal mucosa
Time Frame: during initial surgery
|
After removal of Coloshield by rigid rectoscopy any bleedings or tear injuries in the rectal mucosa (caused by Coloshield) are noted.
It will be documented if there are bleedings or tear injuries or not, and if the exact number of bleedings and tear injuries.
|
during initial surgery
|
Postoperative pain (VAS-score)
Time Frame: during hospitalisation (48h)
|
The pain level on a VAS score from 0 (no pain) to 10 (strongest) 6 hours, 24 hours and 48 hours after surgery are documented.
|
during hospitalisation (48h)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel C Steinemann, MD, Cantonal Hospital Baselland, Switzerland
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (ANTICIPATED)
May 1, 2016
Study Completion (ANTICIPATED)
June 1, 2016
Study Registration Dates
First Submitted
October 14, 2015
First Submitted That Met QC Criteria
October 15, 2015
First Posted (ESTIMATE)
October 19, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
October 19, 2015
Last Update Submitted That Met QC Criteria
October 15, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-341
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhoids
-
Vilnius UniversityBiolitec Pharma Ltd.UnknownHemorrhoids Second Degree | Hemorrhoids Third DegreeLithuania
-
Ventrus Biosciences, IncTerminatedInternal HemorrhoidsUnited States
-
Societa Italiana di Chirurgia ColoRettaleSICCR - Gaetano GalloCompletedSecond-degree HemorrhoidsItaly
-
Medtronic - MITGCompletedHemorrhoids, InternalUnited States
-
The Second Affiliated Hospital of Hunan University...Hunan University of Traditional Chinese Medicine; Zhengfeng Medical Technology...Unknown
-
Universitätsklinikum Hamburg-EppendorfCompletedInternal Hemorrhoids
-
BayerCompletedAcute HemorrhoidsRussian Federation
-
Nivagen Pharmaceuticals Inc.CompletedInternal HemorrhoidsUnited States, India
-
Universidade do PortoCompletedHemorrhoids, InternalPortugal
-
G & W Laboratories Inc.CompletedInternal HemorrhoidsUnited States